Segregation analysis of 389 Icelandic pedigrees with breast and prostate cancer

Genetic Epidemiology

Volumn 23, Issue 4, 2002, Pages 349-363

  Baffoe Bonnie, Agnes B ^a,b,c   Kiemeney, Lambertus A L M ^d   Beaty, Terri H ^a   Bailey Wilson, Joan E ^c   Schnell, Audrey H ^e   Sigvaldason, Helgi ^f   Ólafsdóttir, Guriur ^f   Tryggvadóttir, Laufey ^f   Tulinius, Hrafn ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^e Rammelkamp Center   (United States)

^f ICELANDIC CANCER SOCIETY   (Iceland)

Author keywords

Breast prostate cancer phenotype; Codominant model; Familial aggregation; Sibship covariate

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CODOMINANCE; DISEASE TRANSMISSION; FAMILIAL INCIDENCE; FEMALE; GENE CLUSTER; GENE SEGREGATION; GENETIC RISK; GENOTYPE; HUMAN; ICELAND; INHERITANCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARSIMONY ANALYSIS; PEDIGREE; PHENOTYPE; PROSTATE CANCER; SIBLING;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; ICELAND; MALE; MIDDLE AGED; MODELS, STATISTICAL; PEDIGREE; PROSTATIC NEOPLASMS; REGISTRIES; RISK;

EID: 18744372430     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.10188     Document Type: Article

References (74)

1. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Autom Control 19:716-23.
2. American Cancer Society. 2002. Cancer Facts and Figures. Atlanta, GA: American Cancer Society. http:// www.cancer.org/downloads/STT/CFF2002.pdf
3. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. 2001a. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1-18.
4. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. 2001b. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76-83.
5. Arason A, Barkardottir RB, Egilsson V. 1993. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families and possible relationship to prostatic cancer. Am J Hum Genet 52:711-7.
6. Baffoe-Bonnie AB. 1997. A Genetic Epidemiologic Approach to Studying the Relationship Between Prostate Cancer and Breast Cancer. Doctor of Philosophy dissertation, Johns Hopkins University, Baltimore, MD.
7. Baffoe-Bonnie A, Beaty TH, Bailey-Wilson JE, Kiemeney LA, Sigvaldason H, Olafsdottir G, Tryggvadottir L, Tulinius H. 2000. The genetic epidemiology of breast cancer: Segregation analyses of 389 Icelandic pedigrees. Genet Epidemiol 18:81-94.
8. Barkardottir RB, Sarantaus L, Arason A, Vehmanen P, Bendahl PO, Kainu T, Syrjakoski K, Krahe R, Huusko P, Pyrhonen S, Holli K, Kallioniemi OP, Egilsson V, Kere J, Nevanilnna H. 2001. Haplotype analysis in Icelandic and Finnish BRCA2 999de15 breast cancer families. Eur J Hum Genet 9:773-9.
9. Bergthorsson JT, Johannesdottir G, Arason A, Benediktsdottir KR, Agnarsson BA, Bailey-Wilson JE, Gillanders E, Smith J, Trent J, Barkardottir RB. 2000. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer. Hum Genet 107:372-5.
10. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN, Schaid DJ. 2000. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 67:82-9.
11. Bonney GE. 1986. Regressive logistic models for familial diseases and other binary traits. Biometrics 42:611-25.
12. Breast Cancer Linkage Consortium. 1999. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-6.
13. Cannings C, Thompson EA. 1977. Ascertainment in the sequential sampling of pedigrees. Clin Genet 12:208-12.
14. Cannings C, Thompson EA, Skolnick MH. 1978. Probability functions on complex pedigrees. Adv Appl Probl 10:26-61.
15. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J. 2002. Germline mutations in a ribonuclease L (RNASEL) gene in hereditary prostate cancer 1 (HPC1) linked families. Nat Genet. 30:181-4.
16. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. 1992. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-71.
17. Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP. 1999. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 8:53-60.
18. Chen PL, Sellers TA, Rich SS, Potter JD, Folsom AR. 1995. Segregation analysis of breast cancer in a population-based sample of postmenopausal probands: Iowa Women's Health Study. Genet Epidemiol 12:401-15.
19. Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. 2001a. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 68:1207- 18.
20. Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL. 2001b. After BRCA1 and BRCA2 - What next? Multifactorial segregation analyses of three- generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 68:420-31.
21. Damber L, Gronberg H, Damber JE. 1998. Familial prostate cancer and possible associated malignancies: Nation-wide register cohort study in Sweden. Int J Cancer 78:293-7.
22. Demenais FM, Elston RC. 1981. A general transmission probability model for pedigree data. Hum Hered 31:93-9.
23. Elston RC. 1981. Segregation analysis. Adv Hum Genet 11:63-120.
24. Elston RC. 2000. Introduction and overview. Statistical methods in genetic epidemiology. Stat Methods Med Res 9:527-41.
25. Elston RC, George VT. 1989. Age at diagnosis, age at examination, and other covariates in the analysis of family data. Genet Epidemiol 6:217-20.
26. Elston RC, Sobel E. 1979. Sampling considerations in the gathering and analyses of pedigree data. Am J Hum Genet 27:31-45.
27. Elston RC, Stewart J. 1971. A general model for the analysis of human pedigree data. Hum Hered 21:253-542.
28. Elston RC, Yelverton KC. 1975. General models for segregation analysis. Am J Hum Genet 27:31-45.
29. Essioux L, Abel L, Bonaiti-Pellie C. 1995. Genetic epidemiology of breast cancer: Interest in survival analysis methods. Ann Hum Genet 3:271-82.
30. Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA. 2000. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. Cancer Res 60:4513-8.
31. Gibbs M, Stanford JL, Jarvik GP, Janer M, Badzioch M, Peters MA, Goode EL, Kolb S, Chakrabarti L, Shook M, Basom R, Ostrander EA, Hood L. 2000. A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet 67:100-9.
32. Go RCP, Elston RC, Kaplan EB. 1978. Efficiency and robustness of pedigree segregation analysis. Am J Hum Genet 30:28-37.
33. Gronberg H, Damber L, Damber JE, Iselius L. 1997. Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am J Epidemiol 146:552-7.
34. Gronberg H, Bergh A, Damber JE, Emanuelsson M. 2000. Cancer risk in families with hereditary prostate carcinoma. Cancer 89:1315-21.
35. Gronberg H, Ahman AK, Emanuelsson M, Bergh A, Damber JE, Borg A. 2001. BRCA2 mutation in a family with hereditary prostate cancer. Genes Chromosomes Cancer 30:299-301.
36. Gudmundsson V, Johannesdottir G, Bergthorsson JT, Arason A, Ingvarsson S, Egilsson V, Barkardottir RB. 1996a. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12q13. Cancer Res 55:4830-2.
37. Gudmundsson V, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilsson V, Barkardottir RB. 1996b. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 58:749-56.
38. Isaacs SD, Kiemeney LALM, Baffoe-Bonnie AB, Beaty TH. 1995. The risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 87:991-6.
39. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB. 1996. High prevalence of the 999de15 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663-5.
40. Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H. 2000. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci USA 97:9603-8.
41. Lopez-Otin C, Diamandis EP. 1998. Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 19:365-96.
42. Macklin MT. 1954. The genetic basis of human mammary cancer. In: (Anonymous). Proceedings of Second National Cancer Conference. New York: American Chemical Society. p 1074-87.
43. Meijers-Heijboer H, Van Den Ouweland A, Klijn J, Wasielewski M, De Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, Van Veghel-Plandsoen M, Elstrodt F, Van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton DF, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber BL, Rahman N, Stratton MR. 2002. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-9.
44. Miki Y, Swensen J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Patricia T, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhansen S, Cannon-Albright I., Goldgar D, Wiseman R, Kamb A, Skolnick MH. 1995. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
45. Monne M, Croce CM, Yu H, Diamandis EP. 1994. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 54:6344-7.
46. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. 1995. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1:827-9.
47. Negri E, Braga C, La Vecchia C, Franceschi S, Parazzini F. 1997. Family history of cancer and risk of breast cancer. Int J Cancer 72:735-8.
48. Neuhausen SL. 1999. Ethnic differences in cancer risk resulting from genetic variation. Cancer [Suppl] 86:2575-82.
49. Ostrander EA, Stanford JL. 2000. Genetics of prostate cancer: Too many loci, too few genes. Am J Hum Genet 67:1367-75.
50. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J. 2001. Risk of breast cancer in female flight attendants: A population-based study (Iceland). Cancer Causes Control 12:95-101.
51. Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB. 2000. Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 67:1014-1019.
52. Rosen EM, Fan S, Goldberg ID. 2001. BRCA1 and prostate cancer. Cancer Invest 19:396-412.
53. SAGE. 1997. Statistical Analysis for Genetic Epidemiology, Release 3.1. Computer program package available from the Department of Biometry and Genetics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland.
54. Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN. 1998. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 62:1425-1438.
55. Schwab M, Claas A, Savelyeva L. 2002. BRCA2: A genetic risk factor for breast cancer. Cancer Lett 175:1-8.
56. Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W, Folsom AR. 1994. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 86:1860-5.
57. Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE, Jonsson E. 1997. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 75:758-61.
58. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB. 1996. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 22 274:1371-4.
59. Suarez BK, Lin J, Witte JS, Conti DV, Resnick MI, Klein EA, Burmester JK, Vaske DA, Banerjee TK, Catalona WJ. 2000. Replication linkage study for prostate cancer susceptibility genes. Prostate 45:106-14.
60. Tavtigian SV, Simard J, Labrie F, et al. 2000. A strong candidate prostate cancer predisposition gene at chromosome 17p. Am J Hum Genet [Suppl] 67:7.
61. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA. 2001. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27(2):172-80.
62. Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, Senie R, Daly MB, West D, Ostrander EA, Offit K, Peretz T, Osorio A, Benitez J, Nathanson KL, Sinilnikova OM, Olah E, Bignon YJ, Ruiz P, Badzioch MD, Vasen HF, Futreal AP, Phelan CM, Narod SA, Lynch HT, Ponder BA, Eeles RA, Meijers-Heijboer H, Stoppa-Lyonnet D, Couch FJ, Eccles DM, Evans DG, Chang-Claude J, Lenoir G, Weber BL, Devilee P, Easton DF, Goldgar DE, Stratton MR, KConFab Consortium. 2002. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA 99:827-831.
63. Thorlacius S, Olafsdottir GH, Trygvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE. 1996. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117-119.
64. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tuinius H, Eyfjord JE. 1997. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079-1084.
65. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE. 1998. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337-1339.
66. Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir GH, Bjarnasson T. 1987. Cancer incidence in Iceland 1973-82. In: Muir C, Waterhouse J, Mack T, Powel J, Whelan S, editors. Cancer Incidence in Five Continents. Volume V. Lyon: IARC Scientific Publications, no. 88.
67. Tulinius H, Sigvaldason H, Ólafsdóttir G, Tryggvadóttir L. 1992a. Epidemiology of breast cancer in Iceland. J Med Genet 29:158-164.
68. Tulinius H, Egilsson V, Ólafsdóttir G, Sigvaldason H. 1992b. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br Med J [Clin Res] 305:855-857.
69. Tulinius H, Ólafsdóttir GH, Sigvaldason H, Tryggvadóttir L, Bjarnadottir K. 1994. Neoplastic diseases in families of breast cancer patients. J Med Genet 31:618-621.
70. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadóttir L. 1997. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6:863-873.
71. Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, Egilsson V, Ogmundsdottir HM, Tryggvadottir L, Gudlaugsdottir S, Eyfjord JE. 2002. The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 39(7):457-62.
72. Valeri A, Fournier G, Morin V, Morin JF, Drelon E, Mangin P, Teillac P, Berthon P, Cussenot O. 2000. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first-degree relatives. Int J Cancer 86:883-887.
73. Verhage BA, Baffoe-Bonnie AB, Baglietto L, Smith DS, Bailey-Wilson JE, Beaty TH, Catalona WJ, Kiemeney LA. 2001. Autosomal dominant inheritance of prostate cancer: A confirmatory study. Urology 57:97-101.
74. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Gronberg H, Emanuelsson M, Damber J-E, Bergh A, Bjorn-Anders J, Smith J, Bailey-Wilson J, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van Aucken A, Sood R, Collins F, Brownstein M, Trent J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20:175-179, 1998.